In a recent transcriptome profiling analysis of human neuroblastoma cells, MAPK1 and CRY2 showed significant up- and down-regulation, respectively, during the first 6 h of a NZMF exposure [38]. The gene discussed is CRY2; the disease is neuroblastoma.